Answer
The Vesomni (solifenacin + tamsulosin) warnings highlight pre-existing long QT syndrome and hypokalaemia as examples of risk factors in patients treated with solifenacin succinate who have experienced QT prolongation and torsade de pointes.
Sources for this answer
- Vesomni 6 mg/0.4 mg modified release tabletsAstellas Pharma Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked